Form 4: Atlassian Co-CEO Michael Cannon-Brookes Reports Stock Sales Under 10b5-1 Plan
SEC Form 4
Michael Cannon-Brookes, Co-CEO and Co-Founder of Atlassian, reported the sale of Class A Common Stock on May 7, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Michael Cannon-Brookes, Co-CEO and Co-Founder of Atlassian, reported the sale of Atlassian Class A Common Stock on May 7, 2024.
- The sales were executed under a Rule 10b5-1 trading plan adopted on February 21, 2023.
- A total of 8,741 shares were sold in multiple transactions at varying prices.
- The shares were sold at prices ranging from $179.24 to $184.90.
- The sales were conducted through CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust.
- Following the reported transactions, the number of shares held indirectly by trust is 292,281.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock sales by an executive. It doesn't contain information that would significantly shift investor sentiment positively or negatively.
Industry Context
This filing is a routine disclosure of insider transactions and doesn't necessarily indicate a change in the company's prospects. It is common for executives to use 10b5-1 plans to diversify their holdings and avoid accusations of insider trading.
Stakeholder Impact
- The stock sales could have a minor impact on shareholders due to the increased supply of shares in the market.
Key Dates
| Date | Description |
|---|---|
| 02/21/2023 | Date the Reporting Person adopted a Rule 10b5-1 trading plan |
| 05/07/2024 | Date of the reported stock sales |
| 05/08/2024 | Date of the signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.